Replies to post #4858 on Halozyme Therapeutics Inc (HALO)

[XenaLives]

No,LOL! Pfizer spent all that money on trials of rivipansel just to yank HALO's chain... yeah right....

Pfizer announcing discontinuation of the global clinical development program for bococizumab, its investigational PCSK9 inhibitor. The development of a subcutaneous version on the Halozyme ENHANZE platform has also been discontinued. Pfizer also made a portfolio decision to discontinue development of rivipansel with the ENHANZE platform even though the technology performed as intended. Pfizer continues to develop an additional program with the ENHANZE platform for an undisclosed target. -

See more at: http://www.halozyme.com/investors/news-releases/news-release-details/2016/Halozyme-Reports-Third-Quarter-2016-Financial-Results/default.aspx#sthash.Xgv0iV3N.dpuf